Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 22 | Woolsey Staci MChief Financial Officer |  GVAGRANITE CONSTRUCTION INCOpen-market sale · 10b5-1 plan | SELL | $183K 1,523 sh | Mar 19, 2026 |
| 22 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $321K 2,094 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 21 | Tamari ShaharDirector, COO |  GLBEGlobal-E Online Ltd.Open-market sale · 10b5-1 plan | SELL | $563K 16.7K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 21 | Larkin Kyle TDirector, President & CEO | GVAGRANITE CONSTRUCTION INC Open-market sale · 10b5-1 plan | SELL | $877K 7,314 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner |  DSPViant Technology Inc.Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER |  STOKStoke Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $191K 6,100 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $117K 3,577 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $86K 2,587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 20 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $33K 2,920 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 20 | Beer James ADirector | ZSZscaler, Inc. Open-market sale · 10b5-1 plan | SELL | $27K 177 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 19 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $177K 15.0K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 19 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $59K 5,000 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 18 | Kelly Patrick ArthurCo-President and COO |  CIFRCipher Digital Inc.Open-market sale · 10b5-1 plan | SELL | $533K 35.6K sh | Mar 19, 2026 traded Mar 16, 2026 |
| 16 | Baroni DarioPresident, IDL |  MCDMCDONALDS CORPOpen-market sale · 10b5-1 plan | SELL | $194K 600 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Verjus Nathalie Claude OdileCompany Secretary |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $15K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 15 | Peterson JustinChief Technology Officer |  TWTradeweb Markets Inc.Open-market sale · 10b5-1 plan | SELL | $401K 3,212 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $3,384 103 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $44K 1,461 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 13 | Ticho BarryCHIEF MEDICAL OFFICER | STOKStoke Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $15K 483 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.10M 8,754 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.44M 18.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $2.98M 22.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $3.00M 22.8K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.44M 11.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $5.75M 43.3K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.81M 13.9K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 12 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $1.02M 7,907 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 11 | Wiechmann Andrew C.Chief Financial Officer |  MSCIMSCI Inc.Open-market sale · 10b5-1 plan | SELL | $252K 450 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Weingarten TomerDirector, President, CEO |  SSentinelOne, Inc.Open-market sale · 10b5-1 plan | SELL | $562K 38.9K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $462K 3,624 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Mohan JitendraDirector, Chief Executive Officer | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $728K 5,746 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 9 | Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER |  GKOSGLAUKOS CorpOpen-market sale · 10b5-1 plan | SELL | $62K 625 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth |  DOCUDOCUSIGN, INC.Open-market sale · 10b5-1 plan | SELL | $206K 4,300 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $200K 4,092 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 8 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $189K 3,824 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 6 | Tariq MusaDirector | GHGuardant Health, Inc. Open-market sale · 10b5-1 plan | SELL | $31K 348 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 5 | Rubenstein Andrew H.Director, CEO and President, 10% Owner |  ACELAccel Entertainment, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 3,938 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 4 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $64K 1,395 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 4 | Chatwani RobertPresident General Mgr, Growth | DOCUDOCUSIGN, INC. Open-market sale · 10b5-1 plan | SELL | $144K 3,085 sh | Mar 19, 2026 traded Mar 18, 2026 |